---
title: CMIC HOLDINGS Co., Ltd. vs Ergomed Clinical Research
slug_a: cmicgroup
slug_b: medsource
site: cro
review_signal_gate: closed
canonical_path: /compare/cmicgroup/medsource
generated_by: BioBM Editorial AI
---

# CMIC HOLDINGS Co., Ltd. vs Ergomed Clinical Research

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

CMIC HOLDINGS Co., Ltd. (cmicgroup) is listed for cro. CMIC HOLDINGS is a Japanese contract research and manufacturing organization providing end-to-end pharmaceutical solutions from non-clinical through post-marketing phases, including consulting, CRO, CDMO, and SMO services.

Services: 10. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (10).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Ergomed Clinical Research (medsource) is listed for cro. Ergomed is a specialized CRO with 25+ years of experience delivering oncology, rare disease, and complex clinical trial solutions across all phases globally, backed by a team of 100+ MDs and PhDs.

Services: 7. Modalities: 4. Indications: 2. Locations: 2. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (7).

Review summary: Review summary withheld until site-level review gate opens.